瑞聲科技(2018.HK)午後直線拉昇漲4.5% 蘋果增產10%
格隆匯10月4日丨蘋果供應商瑞聲科技(2018.HK)午後出現直線拉漲走勢,目前漲幅擴大至4.5%,報44.05港元,暫成交2.5億港元,最新總市值534億港元。午間據日媒消息,蘋果已經告知供應商提高新款iPhone 11系列手機的產量多達10%。新款低價手機的全球需求好於預期。港股市場其他蘋果概念股中,通達集團漲超5%,但成交偏淡;比亞迪電子漲超2%;高偉電子和鴻騰精密小幅上漲;富智康集團目前跌2%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.